Related Experiment Videos
Non-invasive ventilation in motor neuron disease: current UK practice
S C Bourke1, T L Williams, R E Bullock
1University of Newcastle, Newcastle upon Tyne NE7 7DN, UK. sbourke@doctors.org.uk
Summary
Few motor neuron disease (MND) patients in the UK receive non-invasive ventilation (NIV). Clinical practice varies significantly, highlighting the need for trials to determine NIV
Area of Science:
- Neurology
- Respiratory Medicine
Background:
- Motor neuron disease (MND) is a progressive neurodegenerative condition affecting nerve cells in the brain and spinal cord.
- Non-invasive ventilation (NIV) is a respiratory support technique that can aid patients with respiratory insufficiency.
Purpose of the Study:
- To evaluate the current clinical application and accessibility of non-invasive ventilation (NIV) for patients with motor neuron disease (MND) across the UK.
- To identify factors influencing the referral of MND patients for NIV.
- To assess the current patterns of NIV use in MND care within the UK.
Main Methods:
- A national postal survey was conducted among consultant neurologists in the UK.
- The survey assessed the percentage of MND patients receiving NIV, access to NIV services, respiratory function monitoring, and referral criteria.
- A follow-up mailing was sent to non-responders to maximize the response rate.
Main Results:
- A 76% response rate was achieved, with data on 2280 patients under review.
- Only 5.5% of reviewed MND patients were receiving NIV, indicating low utilization.
- Referral patterns showed significant variation, with a few neurologists accounting for a large proportion of NIV referrals. Symptoms and disease progression were key referral drivers, while bulbar involvement was often seen as a contraindication.
Conclusions:
- The utilization of NIV in MND patients in the UK is limited and highly variable.
- This variability suggests potential uncertainty regarding NIV's role in MND management.
- There is a clear need for a randomized controlled trial to establish the efficacy of NIV in improving quality of life and survival in MND patients.